Patrick A. Mayes's most recent trade in Incyte Corp. was a trade of 4,218 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Incyte | Patrick A. Mayes | EVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 4,218 | 4,218 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Patrick A. Mayes | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 95.58 per share. | 10 Dec 2025 | 5,553 | 60,266 (0%) | 0% | 95.6 | 530,756 | Common Stock |
| Incyte | Patrick A. Mayes | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 94.94 per share. | 10 Dec 2025 | 255 | 60,011 (0%) | 0% | 94.9 | 24,210 | Common Stock |
| Incyte | Patrick A. Mayes | EVP & Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.70 per share. | 01 Oct 2025 | 1,569 | 65,819 (0%) | 0% | 86.7 | 136,032 | Common Stock |